How the DYT1 gene change affects specific brain cells that control movement
Pathophysiology of DYT1 dystonia: Targeted Mouse Models
Researchers are using specially engineered mice to learn how the DYT1 (TOR1A ΔGAG) genetic change disrupts brain cells involved in movement for people with early-onset DYT1 dystonia.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project ID | NIH-11173797 on NIH RePORTER |
What this research studies
This project uses targeted mouse models that carry the human DYT1/TOR1A mutation to pinpoint which brain regions and cell types cause dystonia-like symptoms. The team focuses on striatal cholinergic interneurons and their interaction with the dopamine system, comparing neuron function, biochemistry, and animal movement. They create conditional knockin and knockout mice and perform cell-specific manipulations to see which changes reproduce or rescue symptoms. Results are aimed at identifying the key cellular targets that could guide future therapies.
Who could benefit from this research
Good fit: People with early-onset generalized DYT1 dystonia who carry the common TOR1A ΔGAG mutation are the population most directly related to this research.
Not a fit: Individuals with non-DYT1 forms of dystonia or without the TOR1A mutation are unlikely to receive direct benefit from this project.
Why it matters
Potential benefit: If successful, the work could identify specific brain cells or circuits to target with future treatments that reduce involuntary movements in DYT1 dystonia.
How similar studies have performed: Earlier mouse models have revealed dopamine and acetylcholine disruptions in dystonia, but using cell-specific knockin approaches to define causal cell types is a newer, more targeted step.
Where this research is happening
Gainesville, United States
- University of Florida — Gainesville, United States (Active)
Researchers
- Principal investigator: Li, Yuqing — University of Florida
- Study coordinator: Li, Yuqing
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.